Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Emerging treatments in type 2 diabetes: focus on canagliflozin

Total article views   Abstract views HTML views PDF downloads Totals
9,355 Dovepress* 5,905 1,454+ 2,202 7,359
PubMed Central* 0 1,996 913 1,996
Totals 5,905 3,450 3,115 9,355
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar